Associations between psychedelic use and adverse outcomes in substance use disorders: a real-world EHR-based cohort study
In this large national cohort, psychedelic use, particularly when combined with anesthetic and outpatient care, was associated with reduced adverse health outcomes among people with SUD. These findings support further investigation into psychedelic-based interventions within integrated treatment frameworks.
Authors
- Ashlie McCunn
- Benjamin Tingey (ORCID: https://orcid.org/0000-0003-0620-0858)
- Fares Qeadan (ORCID: https://orcid.org/0000-0002-3376-220X)
- Paul Thielking
Institutions
- Huntsman (United States) (US)
- Loyola University Chicago (US)
- Huntsman Cancer Institute (US)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2025-10-24
- DOI
- https://doi.org/10.3389/fpsyt.2025.1648104
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00